Pharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits.

<h4>Background</h4>The optimization of snakebite management and the use of antivenom depend greatly on the knowledge of the venom's composition as well as its pharmacokinetics. To date, however, pharmacokinetic reports on cobra venoms and their toxins are still relatively limited. I...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michelle Khai Khun Yap, Nget Hong Tan, Si Mui Sim, Shin Yee Fung, Choo Hock Tan
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
Acceso en línea:https://doaj.org/article/aaec96d2f18d45c6b4242bda1dc6dc25
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aaec96d2f18d45c6b4242bda1dc6dc25
record_format dspace
spelling oai:doaj.org-article:aaec96d2f18d45c6b4242bda1dc6dc252021-11-18T09:15:58ZPharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits.1935-27271935-273510.1371/journal.pntd.0002890https://doaj.org/article/aaec96d2f18d45c6b4242bda1dc6dc252014-06-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24901441/pdf/?tool=EBIhttps://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735<h4>Background</h4>The optimization of snakebite management and the use of antivenom depend greatly on the knowledge of the venom's composition as well as its pharmacokinetics. To date, however, pharmacokinetic reports on cobra venoms and their toxins are still relatively limited. In the present study, we investigated the pharmacokinetics of Naja sumatrana (Equatorial spitting cobra) venom and its major toxins (phospholipase A2, neurotoxin and cardiotoxin), following intravenous and intramuscular administration into rabbits.<h4>Principal findings</h4>The serum antigen concentration-time profile of the N. sumatrana venom and its major toxins injected intravenously fitted a two-compartment model of pharmacokinetics. The systemic clearance (91.3 ml/h), terminal phase half-life (13.6 h) and systemic bioavailability (41.9%) of N. sumatrana venom injected intramuscularly were similar to those of N. sputatrix venom determined in an earlier study. The venom neurotoxin and cardiotoxin reached their peak concentrations within 30 min following intramuscular injection, relatively faster than the phospholipase A2 and whole venom (Tmax=2 h and 1 h, respectively). Rapid absorption of the neurotoxin and cardiotoxin from the injection site into systemic circulation indicates fast onsets of action of these principal toxins that are responsible for the early systemic manifestation of envenoming. The more prominent role of the neurotoxin in N. sumatrana systemic envenoming is further supported by its significantly higher intramuscular bioavailability (Fi.m.=81.5%) compared to that of the phospholipase A2 (Fi.m.=68.6%) or cardiotoxin (Fi.m.=45.6%). The incomplete absorption of the phospholipase A2 and cardiotoxin may infer the toxins' affinities for tissues at the injection site and their pathological roles in local tissue damages through synergistic interactions.<h4>Conclusion/significance</h4>Our results suggest that the venom neurotoxin is absorbed very rapidly and has the highest bioavailability following intramuscular injection, supporting its role as the principal toxin in systemic envenoming.Michelle Khai Khun YapNget Hong TanSi Mui SimShin Yee FungChoo Hock TanPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 8, Iss 6, p e2890 (2014)
institution DOAJ
collection DOAJ
language EN
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Michelle Khai Khun Yap
Nget Hong Tan
Si Mui Sim
Shin Yee Fung
Choo Hock Tan
Pharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits.
description <h4>Background</h4>The optimization of snakebite management and the use of antivenom depend greatly on the knowledge of the venom's composition as well as its pharmacokinetics. To date, however, pharmacokinetic reports on cobra venoms and their toxins are still relatively limited. In the present study, we investigated the pharmacokinetics of Naja sumatrana (Equatorial spitting cobra) venom and its major toxins (phospholipase A2, neurotoxin and cardiotoxin), following intravenous and intramuscular administration into rabbits.<h4>Principal findings</h4>The serum antigen concentration-time profile of the N. sumatrana venom and its major toxins injected intravenously fitted a two-compartment model of pharmacokinetics. The systemic clearance (91.3 ml/h), terminal phase half-life (13.6 h) and systemic bioavailability (41.9%) of N. sumatrana venom injected intramuscularly were similar to those of N. sputatrix venom determined in an earlier study. The venom neurotoxin and cardiotoxin reached their peak concentrations within 30 min following intramuscular injection, relatively faster than the phospholipase A2 and whole venom (Tmax=2 h and 1 h, respectively). Rapid absorption of the neurotoxin and cardiotoxin from the injection site into systemic circulation indicates fast onsets of action of these principal toxins that are responsible for the early systemic manifestation of envenoming. The more prominent role of the neurotoxin in N. sumatrana systemic envenoming is further supported by its significantly higher intramuscular bioavailability (Fi.m.=81.5%) compared to that of the phospholipase A2 (Fi.m.=68.6%) or cardiotoxin (Fi.m.=45.6%). The incomplete absorption of the phospholipase A2 and cardiotoxin may infer the toxins' affinities for tissues at the injection site and their pathological roles in local tissue damages through synergistic interactions.<h4>Conclusion/significance</h4>Our results suggest that the venom neurotoxin is absorbed very rapidly and has the highest bioavailability following intramuscular injection, supporting its role as the principal toxin in systemic envenoming.
format article
author Michelle Khai Khun Yap
Nget Hong Tan
Si Mui Sim
Shin Yee Fung
Choo Hock Tan
author_facet Michelle Khai Khun Yap
Nget Hong Tan
Si Mui Sim
Shin Yee Fung
Choo Hock Tan
author_sort Michelle Khai Khun Yap
title Pharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits.
title_short Pharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits.
title_full Pharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits.
title_fullStr Pharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits.
title_full_unstemmed Pharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits.
title_sort pharmacokinetics of naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/aaec96d2f18d45c6b4242bda1dc6dc25
work_keys_str_mv AT michellekhaikhunyap pharmacokineticsofnajasumatranaequatorialspittingcobravenomanditsmajortoxinsinexperimentallyenvenomedrabbits
AT ngethongtan pharmacokineticsofnajasumatranaequatorialspittingcobravenomanditsmajortoxinsinexperimentallyenvenomedrabbits
AT simuisim pharmacokineticsofnajasumatranaequatorialspittingcobravenomanditsmajortoxinsinexperimentallyenvenomedrabbits
AT shinyeefung pharmacokineticsofnajasumatranaequatorialspittingcobravenomanditsmajortoxinsinexperimentallyenvenomedrabbits
AT choohocktan pharmacokineticsofnajasumatranaequatorialspittingcobravenomanditsmajortoxinsinexperimentallyenvenomedrabbits
_version_ 1718420920745328640